source
- Roche's daily incretin injection shows promise in Phase 2 trial for type 1 diabetesRoche reported that its experimental daily incretin injection achieved positive results in a Phase 2 study involving patients with type 1 diabetes. The study, the first mid-stage trial of a GLP-1…
- CDC warns Ebola could swell to 20,000 cases in Central Africa without rapid containmentThe U.S. Centers for Disease Control and Prevention released a new analysis indicating that the Ebola outbreak in Central Africa could expand to as many as 20,000 cases if infected individuals are…